Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 AUD | -4.88% | +3.02% | +115.26% |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Apr. 04 | Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.27B 849M |
---|---|---|---|---|---|
Net income 2024 * | -37M -24.7M | Net income 2025 * | -48M -32.05M | EV / Sales 2024 * | - |
Net cash position 2024 * | 131M 87.34M | Net cash position 2025 * | 89.22M 59.57M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-34.8
x | P/E ratio 2025 * |
-26.8
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
1 day | -4.88% | ||
1 week | +3.81% | ||
Current month | +46.07% | ||
1 month | +57.31% | ||
3 months | +52.61% | ||
6 months | +208.68% | ||
Current year | +115.26% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 4.09 | -4.88% | 835 337 |
24-05-20 | 4.3 | +3.86% | 899,648 |
24-05-17 | 4.14 | +5.34% | 1,575,053 |
24-05-16 | 3.93 | +2.34% | 861,682 |
24-05-15 | 3.84 | -2.54% | 777,031 |
Delayed Quote Australian S.E., May 21, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+115.26% | 893M | |
+9.40% | 115B | |
+12.71% | 107B | |
-12.83% | 22.31B | |
-3.87% | 21.6B | |
-5.12% | 18.23B | |
-38.57% | 17.62B | |
+7.25% | 14.26B | |
+35.23% | 12.37B | |
-25.82% | 8.28B |
- Stock Market
- Equities
- CU6 Stock